Once-daily dosing with the OROS formulation of methylphenidate has minimal impact on tics in children with ADHD

被引：0
|
作者：
Palumbo, DR
Starr, HL
机构：
来源：
ANNALS OF NEUROLOGY | 2003年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [21] ONCE-DAILY DOSING WITH PHENOBARBITAL IN CHILDREN WITH SEIZURE DISORDERS
    DAVIS, AG
    MUTCHIE, KD
    THOMPSON, JA
    MYERS, GG
    PEDIATRICS, 1981, 68 (06) : 824 - 827
  • [22] Once-daily OROS® methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder
    McGough, James J.
    McBurnett, Keith
    Bukstein, Oscar
    Wilens, Timoth E.
    Greenhill, Laurence
    Lerner, Marc
    Stein, Mark
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (03) : 351 - 356
  • [23] Clinical issues surrounding once-daily aminoglycoside dosing in children
    Knoderer, CA
    Everett, JA
    Buss, WF
    PHARMACOTHERAPY, 2003, 23 (01): : 44 - 56
  • [24] ADHD treatment with once-daily OROS methylphenidate: Interim 12-month results from a long-term open-label study
    Wilens, T
    Pelham, W
    Stein, M
    Conners, CK
    Abikoff, H
    Atkins, M
    August, G
    Greenhill, L
    McBurnett, K
    Palumbo, D
    Swanson, J
    Wolraich, M
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2003, 42 (04): : 424 - 433
  • [25] Once-daily methylphenidate formulation for attention-deficit/hyperactivity disorder evaluated in the community
    Newcorn, J
    Sharma, V
    Stein, MA
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S418 - S419
  • [26] SCHOOL CHILDREN WITH ADHD - EFFECTS OF ONCE-DEALY OROS METHYLPHENIDATE TREATMENT ADHD SYMPTOMS INCLUDED IMPROVEMENT ACADEMIC FUNCTIONING
    Djurkovic-Lazic, J.
    Lazic, B.
    Milojevic, N.
    Djuric, D.
    EUROPEAN PSYCHIATRY, 2009, 24
  • [27] COMPARISON OF MORNING VERSUS EVENING DOSING WITH A NEW ONCE-DAILY ORAL THEOPHYLLINE FORMULATION
    RIVINGTON, RN
    CALCUTT, L
    CHILD, S
    MACLEOD, JP
    HODDER, RV
    STEWART, JH
    AMERICAN JOURNAL OF MEDICINE, 1985, 79 (6A): : 67 - 72
  • [28] An observational study of once-daily modified-release methylphenidate in ADHD: Effectiveness on symptoms and impairment, and safety
    Döpfner M.
    Görtz-Dorten A.
    Breuer D.
    Rothenberger A.
    European Child & Adolescent Psychiatry, 2011, 20 (Suppl 2) : S243 - S255
  • [29] ADHD treatment with once-daily OROS® MPH:: A long-term, open-label study of safety and tolerability
    Wolraich, ML
    PEDIATRIC RESEARCH, 2003, 53 (04) : 555A - 555A
  • [30] Once-daily aminoglycoside dosing: Impact on requests and costs for therapeutic drug monitoring
    Nicolau, DP
    Wu, AHB
    Finocchiaro, S
    Udeh, E
    Chow, MSS
    Quintiliani, R
    Nightingale, CH
    THERAPEUTIC DRUG MONITORING, 1996, 18 (03) : 263 - 266
12345